Suchergebnisse - "Park, Song Ee"

PubPharm (32)

1

Feasibility and safety of exercise during chemotherapy in people with gastrointestinal cancers : a pilot study

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2023

von Park, S. | Kim, D. | Kim, D. | +4

2

Feasibility and safety of exercise during chemotherapy in people with gastrointestinal cancers: a pilot study

enthalten in: Supportive care in cancer | 2023

von Park, S. | Kim, D. | Kim, D. | +4

3

Feasibility and safety of exercise during chemotherapy in people with gastrointestinal cancers: a pilot study

enthalten in: Supportive care in cancer | 2023

von Park, S. | Kim, D. | Kim, D. | +4

4

Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients : KCSG-RC20-06

enthalten in: Cancer medicine | 2023

von Sohn, B. | Kim, J. | Kim, M. | +11

5

Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy

enthalten in: Journal of Cancer | 2023

von Kim, J. | Park, S. | Kim, H. | +1

6

Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients : KCSG‐RC20‐06

enthalten in: Cancer Medicine | 2023

von Sohn, B. | Kim, J. | Kim, M. | +11

7

Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression : Multicenter, real-world data (KCSG LU20-11)

enthalten in: Cancer | 2022

von Kim, H. | Kim, D. | Kim, M. | +10

8

Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer

enthalten in: Journal of Cancer | 2022

von Park, S. | Kim, H. | Jung, E. | +6

9

Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression : Multicenter, real‐world data (KCSG LU20‐11)

enthalten in: Cancer | 2022

von Kim, H. | Kim, D. | Kim, M. | +10

10

Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer

enthalten in: Scientific reports | 2020

von Park, S. | Choi, J. | Park, J. | +6